Medtronic plc — Earnings
Most recent reported period: FY2026 (Q4) (filed for period ending 2026-01-23) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2026-01-23 | $9.02B | ↑+8.7% | $1.14B | ↓-11.7% | 16.2% |
| 2025-10-24 | $8.96B | ↑+6.6% | $1.38B | ↑+8.1% | 18.8% |
| 2025-07-25 | $8.58B | ↑+8.4% | $1.05B | ↓-0.2% | 16.8% |
| 2025-04-25 | $8.93B | ↑+3.9% | $1.06B | ↑+61.5% | 16.1% |
| 2025-01-24 | $8.29B | ↑+2.5% | $1.29B | ↓-2.1% | 19.9% |
| 2024-10-25 | $8.40B | ↑+5.2% | $1.28B | ↑+40.3% | 19.0% |
| 2024-07-26 | $7.92B | ↑+2.8% | $1.05B | ↑+31.6% | 16.1% |
| 2024-04-26 | $8.59B | ↑+0.5% | $654M | ↓-44.5% | 12.3% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2026 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 52 quarters
margin trajectory tells the operating-leverage storyGo deeper
MDT Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyMDT Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics